CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 13 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,005,940 | -31.9% | 2,241,274 | 0.0% | 0.04% | -18.9% |
Q2 2023 | $2,947,275 | -17.3% | 2,241,274 | 0.0% | 0.05% | -24.3% |
Q1 2023 | $3,563,626 | -56.8% | 2,241,274 | -13.1% | 0.07% | -55.7% |
Q4 2022 | $8,250,157 | +28.5% | 2,578,174 | 0.0% | 0.16% | +32.8% |
Q3 2022 | $6,420,000 | -32.7% | 2,578,174 | 0.0% | 0.12% | -31.2% |
Q2 2022 | $9,539,000 | -22.9% | 2,578,174 | 0.0% | 0.17% | -13.9% |
Q1 2022 | $12,375,000 | -30.4% | 2,578,174 | 0.0% | 0.20% | -12.2% |
Q4 2021 | $17,789,000 | -37.7% | 2,578,174 | 0.0% | 0.23% | -27.1% |
Q3 2021 | $28,566,000 | -41.7% | 2,578,174 | 0.0% | 0.31% | -36.7% |
Q2 2021 | $49,037,000 | -33.8% | 2,578,174 | 0.0% | 0.50% | -28.3% |
Q1 2021 | $74,019,000 | – | 2,578,174 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 2,241,274 | $2,005,940 | 0.04% |
Ikarian Capital, LLC | 213,392 | $190,986 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 26,529 | $23,743 | 0.00% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 31,241 | $27,961 | 0.00% |
Qube Research & Technologies Ltd | 44 | $39 | 0.00% |
Moser Wealth Advisors, LLC | 500 | $448 | 0.00% |
Newbridge Financial Services Group, Inc. | 1,100 | $985 | 0.00% |
UBS Group AG | 141 | $126 | 0.00% |
RHUMBLINE ADVISERS | 2,843 | $2,542 | 0.00% |
OSAIC HOLDINGS, INC. | 1,775 | $1,587 | 0.00% |